The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Allina Physicians File Notice for Sept. 14-17 Strike

By Healthcare Technology News ·

More than 150 physicians at Allina Health's Mercy and Unity hospitals in Minnesota are set to strike from Sept. 14 to 17, according to Becker's Hospital Review. Their union, Doctors Council SEIU, filed the required 10-day notice for an unfair labor practice strike in a Sept. 5 news release.

The bargaining unit is broad, covering hospitalists, OB-GYNs, psychiatrists and critical care physicians. That mix matters: these are frontline roles central to inpatient care, so a walkout at two hospitals could force Allina to lean on temporary staffing and contingency coverage to keep services running.

The action reflects a wider shift. Physicians, long resistant to organized labor, are increasingly unionizing as more work as employees of large health systems rather than in independent practice. Disputes over staffing, workload and working conditions are driving that trend. For hospital executives, the Allina notice is a signal that physician labor relations are becoming an operational and financial risk to plan for, not an edge case.

Sources

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.